- Home
- Equities - Stocks - Shares
- Company Press Releases
- Gimv Exits Biolam To Its Management Backed By Investors After a Fast and Successful Growth Trajectory Into a Leading French Group of Clinical Testing Labs
09 Dec 2022 07:30 CET
GIMV
See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo
Gimv
Les Echos
GIMV
BE0003699130
GIMB
Euronext